MPI Positioned by Strong Global IP Portfolio

The intellectual property of Medical Prognosis Institute is protected primarily by two patent families, one concerning Drug Response Prediction and Chemosensitivity, the other concerning Cancer Prognosis. Both are currently in the PCT phase.

Announcements